Aktienanalyse zu QT Imaging Holdings Inc (QTI)QTIQT Imaging Holdings Inc

QT Imaging Holdings, Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low-frequency sound waves. The Company's products include QTI Breast Acoustic CT Scanner and QTviewer Software. QTI’s Breast Acoustic CT scanner with QTViewer viewer software is the only three-dimensional (3D) imaging device to receive United States Food and Drug Administration (FDA) clearance for use as a transmission and reflection ultrasonic imaging system of a patients breast. QTviewer is its proprietary image viewing and analysis platform, purpose-built to interpret the rich, quantitative datasets generated by the QTI Breast Acoustic CT™ scanner. The QTviewer allows users to rotate, zoom, and cross-navigate entire breast volumes. Whether isolating lesions or exploring architectural distortion, radiologists can interact with the data dynamically to gain an understanding of tissue structure and lesion morphology. It operates in the Healthcare sector (ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS industry).

QT Imaging Holdings Inc (QTI) presents a compelling buy opportunity at the current price of $2.03, especially considering its recent 103% revenue growth in Q2 2026, which indicates strong market demand. The RSI is at a low 19.071, suggesting the stock is oversold and may rebound. However, the main risk is the significant net income loss of $11.07 million in Q2 2026, which investors should monitor closely.